Use of Existing Fibroblast Cells to Convert to Induced Pluripotent Stem Cells
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHadassah Medical Organization
About this trial
Induced pluripotent stem cells potentially may be useful in the future as an unlimited source of cells for transplantation.
The major goal of the project is to develop human iPS cells from existing lines of fibroblasts that were originally donated as clinical grade feeders for the development of clinical grade hESCs. The clinical grade feeders were developed from aborted fetuses, foreskin and umbilical cord.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
healthy, older than 18
Disqualifiers
non healthy, younger than 18
Trial population
pregnant, healthy females older than 18 who signed an informed consent for the termination of the pregnancy. pregnant healthy couples older than 18 who signed an informed consent for a c-section. healthy male newborns, undergoing surgical circumcision who's parents older than 18 signed an informed consent.
Trial design
Design model
Case-control
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
1 Participants
are grouped into 1 trial groupGroup A: Pre-existing Fibroblast MCB
Trial outcomes
This trial has no outcomes listed.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov